A Comprehensive AI-Based Approach in Classifying Breast Lesions: Focusing on Improving Pathologists’ Accuracy and Efficiency
Clinical Breast Cancer · 2025-08 · 25 (6) · e818-e825
DOI: 10.1016/j.clbc.2025.03.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Breast Cancer, 2025-08. Verfasst von Maryam Tahir und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH. Hauptthemen laut MEDLINE: Breast Neoplasms, Artificial Intelligence, Pathologists, Carcinoma, Intraductal, Noninfiltrating. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Accurate classification of breast lesions is essential for effective clinical decision-making and patient management. In this study, we evaluated an artificial intelligence (AI) solution to classify whole slide images (WSIs) of breast lesions. METHODS: We analyzed a cohort of 104 breast cases, including 20 invasive carcinomas, 4 microinvasive carcinomas, 15 ductal Carcinoma in situ (DCIS) cases, and 65 lobular neoplasia/benign cases. The AI's performance was compared with the ground truth established by breast pathologists. RESULTS: For invasive carcinoma, it achieved an area under the curve (AUC) of 0.976, with sensitivity and specificity of 91.7% (84.4%, 95.4%) and 95% (88.0% 97.3%) respectively. For DCIS, the AUC was 0.976, with sensitivity and specificity of 93.3% and 96.6%. For lobular neoplasm, it achieved an AUC of 0.953, sensitivity of 94.1%, and specificity of 95.8%. The AI also performed well in detecting microcalcifications, with an AUC of 0.925 and sensitivity of 95%. Pathologists' diagnostic accuracy improved from 97.1% to 100% with AI support (303 vs. 312 accurate case reads per arm). Additionally, the AI use significantly enhanced the pathologists' efficiency, reducing their review time by an average of 16.5% across the 3 pathologists and led to a 33% reduction in immunohistochemistry usage. CONCLUSION: This study highlights the potential of AI in breast lesion classification, demonstrating high sensitivity, specificity, and efficiency, and supports its integration into routine pathology practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH.
- Ibex Medical Analytics, Tel Aviv, Israel.
- Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH. Electronic address: Zaibo.Li@osumc.edu.
Zitieren
APA
Tahir, M., Hu, Y., Kumar, H., Shaker, N., Kellough, D., Goodman, S., Vecsler, M., Lujan, G., Frankel, W. L., Parwani, A. V., & Li, Z. (2025). A Comprehensive AI-Based Approach in Classifying Breast Lesions: Focusing on Improving Pathologists’ Accuracy and Efficiency. Clinical Breast Cancer, 25(6), e818-e825. https://doi.org/10.1016/j.clbc.2025.03.016
Vancouver
Tahir M, Hu Y, Kumar H, Shaker N, Kellough D, Goodman S, et al. A Comprehensive AI-Based Approach in Classifying Breast Lesions: Focusing on Improving Pathologists’ Accuracy and Efficiency. Clinical Breast Cancer. 2025;25(6):e818-e825. doi:10.1016/j.clbc.2025.03.016
BibTeX
@article{Tahir2025,
author = {Tahir, Maryam and Hu, Yan and Kumar, Himani and Shaker, Nada and Kellough, David and Goodman, Shaya and Vecsler, Manuela and Lujan, Giovanni and Frankel, Wendy L and Parwani, Anil V and Li, Zaibo},
title = {A Comprehensive AI-Based Approach in Classifying Breast Lesions: Focusing on Improving Pathologists’ Accuracy and Efficiency},
journal = {Clinical Breast Cancer},
year = {2025},
volume = {25},
number = {6},
pages = {e818--e825},
doi = {10.1016/j.clbc.2025.03.016}
}
EUVIMED